Opportunistic capital raise with proceeds used to enhance strategic flexibility to invest for future growth Approximately $300 million of the ...

Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of 100% and to repurchase ...

Opportunistic capital raise for general corporate purposes Either net proceeds from this offering or cash on hand to be used to purchase cash-settled capped calls to offset economic dilution up to a ...

Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. An announcement from Bandwidth ( (BAND)) is now available. On June 15, 2026, Bandwidth Inc.

(NASDAQ/TSX: KEEL), a North American digital and energy infrastructure company (“Keel” or the “Company”), today announced that it has closed its offering of $458 million aggregate principal amount of ...

Opportunistic capital raise with proceeds used to support exploration and development of the Panuco Project, potential future acquisitions, and general corporate purposes A portion of the proceeds to ...

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion”) (NYSE: MIR), today announced its intent to offer $250.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the ...

Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the underwriters have exercised ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Arrowhead Pharmaceuticals (ARWR) announced its public offerings, pricing $625M of 0.00% convertible senior notes due in 2032 and 3.1M shares of common stock at $64.50 per share. Instead of common ...